The incidence of cancer in northern Sweden increased following the accident at the nuclear power plant in Chernobyl in 1986. This was the finding of a much-debated study from Linköping University in Sweden from 2004.
Was the increase in cancer caused by the radioactive fallout from Chernobyl or could it be explained by other circumstances? New research from Linköping University provides scientific support for the Chernobyl connection.
“This issue is important because the indicated increased risk may come to influence the prevailing exposure limits for the population. Enhanced knowledge of the risks entailed by radioactive radiation is key to work for radiation safety and makes it possible to prevent diseases,” says Martin Tondel, a physician and researcher in environmental medicine who will soon be defending his doctoral dissertation Malignancies in Sweden after the Chernobyl Accident in 1986.
In two studies using different methods, Martin Tondel has shown a small but statistically significant increase in the incidence of cancer in northern Sweden, where the fallout of radioactive cesium 137 was at its most intense.
The cancer risk increased with rising fallout intensity: up to a 20-percent increase in the highest of six categories. This means that 3.8 percent of the cancer cases up to 1999 can be ascribed to the fallout. This increased risk, in turn, is 26 times higher than the latest risk estimate for the survivors of the atom bombs in Hiroshima and Nagasaki, whose exposure was many times higher.
The increase in Tondel’s studies came a remarkably short time after the disaster, since it is usually assumed that it takes decades for cancer to develop. The dissertation discusses the interpretation of the research findings from the perspective of the theory of science.
The conclusion is that there is scientific support for a connection between the radioactive fallout and the increase in the number of cancer cases.
Source: Linköping University
Related stories:
Researchers discover atomic bomb effect results in adult-onset thyroid cancer
Radiation from the atomic bomb blasts in Hiroshima and Nagasaki, Japan, in 1945, likely rearranged chromosomes in some survivors who later developed papillary thyroid cancer as adults, according to Japanese researchers.
Chernobyl: The true scale of the accident
20 years later a UN report provides definitive answers and ways to repair lives
A total of up to four thousand people could eventually die of radiation exposure from the Chernobyl nuclear power plant (NPP) accident nearly 20 years ago, an international team of more than 100 scientists has concluded.
Why bladder cancer is deadlier for some
Bladder cancer is much more likely to be deadly for women and African-Americans, but the reasons long believed to explain the phenomenon account for only part of the differences for such patients compared to their white and male counterparts, according to results published in the Jan. 1 issue of the journal
Cancer.
Hormone therapy associated with reduced colorectal cancer risk
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of
Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
Chemopreventive agents in black raspberries identified
A study published in
Cancer Prevention Research, a journal of the American Association for Cancer Research, identifies components of black raspberries with chemopreventive potential.
Melanoma doubles risk of new cancer: study
People who have been treated for a melanoma have more than twice the risk of developing another form of cancer, according to a study published Wednesday.
Baby teeth re-studied for effects of radiation fallout
Questionnaires will soon be sent to thousands of men who donated their baby teeth half a century ago to scientists seeking to learn whether radioactive fallout in milk the donors drank as children affected their health later in life. It's the latest step in a study that began in the 1950s and 1960s at Washington University, but then stalled for decades.
New hope for cancer comes straight from the heart
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the
Proceedings of the National Academy of Sciences, researchers at the Johns Hopkins University School of Medicine now report that this same class of drugs may hold new promise as a treatment for cancer. This finding emerged through a search for existing drugs that might slow or stop cancer progression.